E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder
Part of paid clinical trials in New York, New York.
- Sponsor
- NYU Langone Health
- Study ID
- NCT05722561
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Cigarette Smoking
- Opioid Use Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Telehealth Motivational Counseling — BEHAVIORALAt baseline, after randomization, participants will receive their first telehealth session (20\~25 minutes) from a counselor trained in motivational interviewing, harm reduction, and smoking cessation. Four additional sessions will be delivered (weeks 2, 3, 4, 6), 15\~20 minutes each.
- Nicotine Replacement Product — DRUGCombination nicotine replacement therapy with lozenges and patches. Participants are recommended to use the NRT according to product directions.
- National Institute on Drug Abuse (NIDA) Standardized Research Electronic Cigarette (SREC). — DEVICEParticipants are to use the electronic cigarette freely as replacement for smoking combustible cigarettes.
Study Details
The purpose of this an open-label, randomized controlled trial study is to compare the effectiveness of electronic cigarettes (e-cigarettes/e-cigs) versus telehealth motivational counseling with combination nicotine replacement therapy (NRT) + telehealth counseling on combustible cigarettes smoking reduction among persons with opioid use disorder (OUD) in methadone and buprenorphine treatment programs (opioid use disorder treatment programs (OUDTP)). OUDTP patients are a population with exceptionally high combustible cigarettes smoking burden and yet limited success in achieving meaningful clinical outcomes in tobacco treatment. If effective, electronic cigarettes would provide an additional tool for tobacco harm reduction among this difficult-to-treat vulnerable population.
Key Dates
- Start date
- Aug 8, 2024
- Status verified
- Mar 2026
- Primary completion
- Nov 1, 2026
- Completion
- Mar 1, 2027
Study Design
- Enrollment
- 302 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Electronic CigaretteParticipants in the Electronic Cigarette (EC) arm will receive telehealth motivational counseling for 5 weeks plus the standardized research e-cigarette (SREC).
- Active Comparator: Nicotine Replacement TherapyParticipants in the Nicotine Replacement Therapy (NRT) arm will receive telehealth motivational counseling plus combination NRT (patch and lozenge).
Primary Outcome Measure
Percentage of Participants who Achieve 100% Reduction in Cigarettes Per Day (CPD) between Baseline and End of Intervention (Visit 5) [ Time Frame: Up to Visit 5 (Day 56) ]
Central Contacts
- Omar El-Shahawy, MD, MPH, PhD646-501-3587
- Mohsen Abbasi, MD, MPH646-501-3581
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| NYU Langone Health | New York | New York | 10016 | |
| Albert Einstein College of Medicine | The Bronx | New York | 10461 | Shadi Nahvi, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in New York, NY
Related Studies
- Low-dose Buprenorphine Initiation for Opioid Use DisorderPHASE4 · Recruiting · Montefiore Medical Center · The Bronx, New York
- IMPOWR-ME Project 1: Trial of Yoga and Physical Therapy Onsite at Opioid Treatment ProgramsRecruiting · Albert Einstein College of Medicine · The Bronx, New York
- Postpartum Intervention for Mothers With Opioid Use DisordersRecruiting · Stony Brook University · Ann Arbor, Michigan
- E-cigarettes for Harm Reduction Among Smokers With Serious Mental IllnessRecruiting · NYU Langone Health · New York, New York